Pro-Dex (PDEX) Competitors $49.43 -0.39 (-0.78%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$49.32 -0.12 (-0.23%) As of 07/25/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. BBNX, EMBC, SMLR, CBLL, KIDS, AVNS, BVS, AXGN, BFLY, and DCTHShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Beta Bionics (BBNX), Embecta (EMBC), Semler Scientific (SMLR), CeriBell (CBLL), OrthoPediatrics (KIDS), AVANOS MEDICAL (AVNS), Bioventus (BVS), AxoGen (AXGN), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Beta Bionics Embecta Semler Scientific CeriBell OrthoPediatrics AVANOS MEDICAL Bioventus AxoGen Butterfly Network Delcath Systems Pro-Dex (NASDAQ:PDEX) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations. Does the media prefer PDEX or BBNX? In the previous week, Beta Bionics had 6 more articles in the media than Pro-Dex. MarketBeat recorded 7 mentions for Beta Bionics and 1 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.87 beat Beta Bionics' score of 0.86 indicating that Pro-Dex is being referred to more favorably in the media. Company Overall Sentiment Pro-Dex Very Positive Beta Bionics Positive Is PDEX or BBNX more profitable? Pro-Dex has a net margin of 14.61% compared to Beta Bionics' net margin of 0.00%. Pro-Dex's return on equity of 29.08% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex14.61% 29.08% 16.19% Beta Bionics N/A N/A N/A Do institutionals & insiders believe in PDEX or BBNX? 15.3% of Pro-Dex shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer PDEX or BBNX? Pro-Dex presently has a consensus price target of $56.00, indicating a potential upside of 13.29%. Beta Bionics has a consensus price target of $23.44, indicating a potential upside of 57.98%. Given Beta Bionics' higher possible upside, analysts plainly believe Beta Bionics is more favorable than Pro-Dex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75 Which has better earnings & valuation, PDEX or BBNX? Pro-Dex has higher earnings, but lower revenue than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$53.84M2.99$2.13M$2.8017.65Beta Bionics$65.12M9.88-$54.76MN/AN/A SummaryPro-Dex beats Beta Bionics on 8 of the 14 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$162.46M$15.92B$5.70B$9.50BDividend YieldN/A1.41%4.69%4.01%P/E Ratio17.6518.9528.1020.06Price / Sales2.992.46428.7189.10Price / Cash52.0317.9036.2258.56Price / Book5.474.008.665.87Net Income$2.13M$430.42M$3.25B$258.55M7 Day Performance7.01%5.58%4.22%3.73%1 Month Performance14.66%5.17%10.51%11.75%1 Year Performance163.07%23.10%34.40%18.02% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex2.4778 of 5 stars$49.43-0.8%$56.00+13.3%+159.1%$162.46M$53.84M17.65140Positive NewsBBNXBeta BionicsN/A$14.30+5.2%$23.44+63.9%N/A$589.21M$65.12M0.00294News CoverageLockup ExpirationEMBCEmbecta4.6895 of 5 stars$10.29+5.2%$19.00+84.6%-26.1%$571.57M$1.12B11.432,100SMLRSemler Scientific3.3002 of 5 stars$39.67-3.8%$89.00+124.4%+18.5%$568.63M$56.29M-15.20120CBLLCeriBell2.3135 of 5 stars$15.21-2.4%$32.14+111.3%N/A$563.11M$65.44M0.00N/AKIDSOrthoPediatrics4.1988 of 5 stars$21.88-0.6%$35.83+63.8%-30.8%$534.55M$204.73M-12.50200AVNSAVANOS MEDICAL2.9121 of 5 stars$11.40+1.6%N/A-47.6%$518.86M$687.80M-1.362,227News CoverageBVSBioventus3.3542 of 5 stars$6.30+0.6%$13.75+118.3%-11.8%$517.51M$567.70M-10.331,200AXGNAxoGen2.219 of 5 stars$11.61+2.9%$24.50+111.0%+43.3%$513.74M$194.52M-77.39450BFLYButterfly Network2.4812 of 5 stars$1.89+0.8%$3.50+85.7%+85.4%$462.43M$82.06M-6.50460News CoverageUpcoming EarningsDCTHDelcath Systems2.7676 of 5 stars$11.32+0.6%$24.00+112.0%+31.1%$391.80M$37.21M-22.6460News Coverage Related Companies and Tools Related Companies BBNX Competitors EMBC Competitors SMLR Competitors CBLL Competitors KIDS Competitors AVNS Competitors BVS Competitors AXGN Competitors BFLY Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredThe AI Chip Trade is OUT. This is in…Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PDEX Stock Alerts